background
role
respiratori
virus
pathogenesi
bronchiol
reevalu
use
molecular
method
pcr
viru
detect
whether
specif
virus
classic
clinic
risk
factor
import
determin
sever
bronchiol
well
establish
aim
analyz
specif
virus
clinic
variabl
predict
sever
bronchiol
admiss
method
nasopharyng
aspir
prospect
collect
children
month
admit
pediatr
ward
picu
universitari
hospit
sant
joan
de
u
barcelona
spain
bronchiol
octob
octob
clinic
demograph
data
collect
sixteen
respiratori
virus
studi
use
pcr
sever
assess
bronchiol
clinic
score
bc
result
four
hundr
ten
infant
test
posit
respiratori
virus
analyz
mix
viral
infect
increas
sever
diseas
rhinoviru
associ
sever
bc
univari
analysi
p
multivari
logist
regress
includ
virus
clinic
data
bronchopulmonari
dysplasia
ci
congenit
heart
diseas
ci
prematur
ci
fever
ci
show
statist
signific
predict
sever
bc
conclus
classic
clinic
risk
factor
weight
predict
sever
bc
infant
acut
bronchiol
involv
virus
acut
respiratori
infect
major
caus
hospit
pediatr
popul
especi
earli
year
life
acut
bronchiol
one
bestcharacter
respiratori
diseas
infant
around
children
younger
year
age
admit
hospit
bronchiol
patient
requir
admiss
pediatr
intens
care
unit
picu
human
respiratori
syncyti
viru
hrsv
commonli
identifi
viru
detect
hospit
infant
respiratori
virus
includ
parainfluenza
viru
coronaviru
adenoviru
rhinoviru
hrv
recent
human
metapneumoviru
hmpv
human
bocaviru
hbov
describ
signific
caus
acut
bronchiol
highrisk
group
sever
bronchiol
infant
younger
week
old
predispos
condit
prematur
congenit
heart
diseas
chd
past
decad
develop
addit
support
inform
may
found
onlin
version
articl
new
molecular
techniqu
viru
detect
role
variou
respiratori
virus
pathogenesi
acut
bronchiol
reevalu
hrv
preval
caus
upper
respiratori
infect
older
children
adult
increasingli
recogn
import
agent
caus
acut
bronchiol
role
develop
acut
respiratori
tract
infect
controversi
detect
asymptomat
individu
moreov
associ
sever
cours
diseas
addit
viral
coinfect
also
relat
sever
bronchiol
whether
tradit
clinic
risk
factor
data
concern
infect
specif
virus
weight
develop
sever
cours
infant
affect
acut
bronchiol
remain
unknown
aim
studi
assess
clinic
factor
virus
involv
case
sever
bronchiol
defin
sever
accord
respiratori
burden
use
bronchiol
clinic
score
bc
secondli
aim
investig
clinic
factor
specif
respiratori
virus
use
predict
sever
outcom
diseas
admiss
prospect
studi
infant
month
acut
bronchiol
hospit
octob
octob
pediatr
ward
picu
hospit
sant
joan
de
deu
tertiari
univers
hospit
locat
barcelona
spain
bronchiol
diagnos
accord
presenc
first
acut
respiratori
tract
infect
character
respiratori
distress
tachypnea
use
accessori
muscl
cough
widespread
crackl
wheez
associ
sign
viral
infect
coryza
exclus
criteria
underli
chronic
pulmonari
diseas
pulmonari
bronchodysplasia
bpd
order
exclud
patient
born
prematur
known
risk
sever
bronchiol
recurr
one
wheez
episod
apnea
secondari
known
diseas
gastroesophag
reflux
demonstr
phmetri
esophagogastroduoden
transit
metabol
neurolog
diseas
respiratori
symptom
due
bronchoaspir
patient
admit
hospit
one
follow
criteria
present
puls
oximetri
less
room
air
persist
stay
emerg
room
minimum
hr
poor
feed
risk
dehydr
apnea
moder
bronchiol
defin
bc
equal
greater
six
point
known
cardiorespiratori
diseas
chd
bpd
young
age
child
less
week
bc
modifi
wooddown
score
assess
auscult
transcutan
hemoglobin
satur
respiratori
effort
heart
rate
respiratori
rate
accord
age
score
rang
point
e
fig
criteria
picu
admiss
acut
respiratori
failur
sever
hypoxemia
puls
oximetri
oxygen
supplement
greater
sepsi
defin
accord
intern
consensu
confer
pediatr
sepsi
frequent
apnea
requir
vigor
stimul
sever
bronchiol
pneumonia
acidosi
ph
less
rapidli
progress
diseas
sever
bronchiol
defin
maximum
bc
equal
greater
point
ill
accord
hospit
bronchiol
clinic
practic
guidelin
inform
consent
obtain
patient
parent
ethic
committe
hospit
clinic
hospit
sant
joan
de
approv
studi
protocol
demograph
epidemiolog
clinic
laboratori
data
obtain
use
standard
questionnair
record
variabl
includ
age
sex
birth
histori
gestat
age
birth
weight
need
neonat
admiss
use
palivizumab
prophylaxi
prescrib
accord
american
academi
pediatr
recommend
person
histori
atopi
famili
histori
asthma
atopi
firstdegre
rel
presenc
underli
chronic
condit
hemodynam
signific
chd
defin
either
use
medic
control
congest
heart
failur
infant
moder
sever
pulmonari
hypertens
cyanot
heart
diseas
bpd
defin
jobe
bancalari
polymalform
syndrom
chromosomopathi
sever
neurolog
impair
consid
signific
chronic
condit
emerg
room
weight
vital
sign
heart
rate
respiratori
rate
axillari
temperatur
transcutan
hemoglobin
satur
sever
accord
bc
e
fig
day
coryza
day
respiratori
effort
prior
admiss
histori
fever
regist
caretak
hr
prior
admiss
record
case
septicappear
infant
without
fever
axillari
measur
rectal
temperatur
taken
regist
case
discrep
inpati
manag
follow
data
record
day
oxygen
therapi
maximum
fraction
inspir
oxygen
fio
need
test
perform
result
chest
xray
laboratori
microbiolog
data
day
nasogastr
feed
tube
need
length
respiratori
support
either
mechan
ventil
noninvas
ventil
need
length
stay
picu
diagnosi
discharg
length
hospit
radiolog
find
review
radiologist
classifi
accord
sever
peribronchi
infiltr
hyperinfl
without
consolid
atelectasi
peribronchi
infiltr
hyperinfl
mildtomoder
consolid
atelectasi
extens
consolid
atelectasi
without
hyperinfl
diseas
could
worsen
admiss
bc
assess
daili
highest
score
observ
hospit
retain
determin
sever
diseas
maximum
bc
nasopharyng
aspir
studi
respiratori
virus
collect
emerg
room
within
first
hr
admiss
aliquot
sampl
use
perform
rapid
immunochromatographi
test
detect
hrsv
clearview
rsv
unipath
emerg
lab
afterward
sampl
deliv
laboratori
microbiolog
hospit
clinic
barcelona
process
pcr
viru
detect
total
nucleic
acid
extract
ml
fresh
specimen
elut
ml
rnasefre
elut
buffer
use
nuclisens
easymag
marci
franc
accord
manufactur
instruct
lysi
buffer
includ
molecul
clone
amplifi
product
use
intern
control
reaction
tube
exclud
falseneg
result
due
nonspecif
inhibitor
extract
failur
two
independ
multiplex
nest
rtpcr
assay
perform
describ
coira
et
al
first
multiplex
rtpcr
assay
detect
influenza
b
c
virus
human
adenoviru
hrsv
b
subtyp
anoth
rtpcr
assay
studi
human
parainfluenza
virus
human
coronaviru
hrv
human
enteroviru
order
detect
hbov
hmpv
subtyp
b
realtim
multiplex
rtpcr
use
set
primer
probe
hbov
specif
gene
forward
primer
revers
primer
probe
vic
ccttcctcatagtgctgac
mgb
design
use
primer
express
softwar
appli
biosystem
foster
citi
ca
set
primer
probe
specif
fusion
gene
subtyp
hpmv
previous
describ
use
label
mgb
realtim
rtpcr
reaction
carri
use
stratagen
la
jolla
ca
urin
cultur
blood
cultur
taken
case
infant
less
month
old
fever
axillari
rectal
temperatur
infant
age
temperatur
equal
greater
septic
appear
lumbar
punctur
done
febril
infant
month
older
suspect
sepsi
picu
set
bronchoalveolar
lavag
cultur
done
case
suspicion
bacteri
coinfect
central
line
cathet
cultur
patient
suspect
nosocomi
infect
bacterialyeast
coinfect
defin
grow
pathogen
microorgan
blood
urin
cerebrospin
fluid
bronchoalveolar
lavag
fluid
order
assess
variabl
relat
sever
diseas
term
respiratori
symptom
patient
divid
two
group
comparison
children
reach
maximum
bc
equal
greater
point
admiss
hospit
stay
classifi
sever
children
maximum
bc
less
point
classifi
nonsever
group
descript
statist
discret
variabl
report
term
absolut
frequenc
percentag
data
comparison
made
use
chisquar
test
fisher
exact
test
appropri
continu
nonnorm
distribut
variabl
describ
median
first
third
quartil
bivari
associ
assess
student
ttest
normal
distribut
variabl
mannwhitney
utest
nonnorm
distribut
pvalu
consid
signific
multivari
logist
regress
analys
use
evalu
risk
factor
sever
diseas
initi
univari
model
perform
introduc
independ
variabl
age
gestat
age
weight
person
famili
histori
atopi
presenc
underli
chronic
condit
bpd
chd
signific
chromosomopathi
polymalform
syndrom
sever
neurolog
disabl
presenc
fever
admiss
previou
hr
day
coryza
day
respiratori
effort
prior
admiss
respiratori
virus
test
subsequ
variabl
signific
associ
p
univari
model
variabl
known
potenti
confound
palivizumab
immunoprophylaxi
hrsv
infect
introduc
multivari
model
stepwis
approach
elimin
possibl
mutual
confound
interact
risk
express
odd
ratio
confid
interv
ci
multivari
odd
ratio
ci
includ
consid
signific
analys
perform
use
pasw
statist
softwar
fivehundr
sixtythre
patient
admit
bronchiol
studi
period
exclud
meet
least
one
exclus
criteria
insuffici
nasopharyng
aspir
sampl
meet
standard
admiss
criteria
admit
parent
discomfort
lack
followup
four
hundr
eightyfour
hospit
infant
bronchiol
includ
four
hundr
ten
infant
test
posit
viru
detect
singl
viru
one
viru
e
fig
order
investig
role
respiratori
virus
clinic
cours
patient
bronchiol
infant
posit
result
viru
detect
includ
analysi
total
n
patient
demograph
diseas
characterist
shown
tabl
virus
coinfect
assess
separ
tabl
total
virus
detect
posit
sampl
common
pathogen
hrsv
viru
detect
follow
hrv
hbov
human
adenoviru
among
infant
hrsv
bronchiol
underli
chronic
ill
gestat
age
week
contrast
infant
nonhrsv
bronchiol
whose
proport
p
p
respect
palivizumab
iqr
interquartil
rang
bpd
bronchopulmonari
dysplasia
chd
congenit
heart
diseas
picu
pediatr
intens
care
unit
bc
bronchiol
clinic
score
number
parenthes
repres
percentag
calcul
patient
underli
chronic
ill
two
patient
syndrom
sd
craneofaci
malform
facial
subglot
angioma
polymalform
sd
without
specif
diagnosi
pierrerobin
sequenc
arthrogryposi
trombocytopenia
interventricular
defect
ventriculomegali
charg
sd
branchioot
bo
sd
rubinsteintaybi
sd
polymalform
sd
without
specif
diagnosi
anorect
malform
congenit
diaphragmat
hernia
aortic
arch
hypoplasia
temperatur
admiss
hr
immunoprophylaxi
date
patient
indic
presenc
fever
admiss
hr
show
statist
signific
associ
find
xray
consolid
atelectasi
p
infant
fever
mildtomoder
xray
opac
extens
consolid
atelectasi
concomitantli
viral
respiratori
infect
patient
bacterialyeast
infect
patient
patient
urinari
tract
infect
escherichia
coli
klebsiella
oxytoca
streptococcu
faecali
candida
albican
patient
posit
blood
cultur
streptococcu
pneumonia
neisseria
meningitidi
patient
posit
cultur
protect
bronchoalveolar
lavag
pneumonia
pseudomona
aeruginosa
enterobact
cloaca
infant
bacteri
coinfect
detect
picu
nosocomi
infect
patient
remain
pediatr
ward
eightytwo
patient
experienc
sever
bc
hospit
stay
patient
sever
group
increas
mean
length
stay
compar
nonsever
group
day
standard
deviat
vs
day
sd
p
increas
day
oxygen
therapi
day
sd
vs
day
sd
p
increas
maximum
fio
requir
mean
fio
sd
vs
sd
p
increas
day
nasogastr
feed
tub
rang
vs
rang
day
p
greater
picu
admiss
vs
p
greater
need
respiratori
support
either
noninvas
ventil
vs
p
mechan
ventil
vs
p
patient
nonsever
group
requir
picu
admiss
respiratori
support
due
develop
apnea
twentyon
infant
went
picu
apnea
nonsever
sever
group
presenc
bacteri
coinfect
also
correl
sever
infant
coinfect
bacteria
sever
bc
p
univari
analysi
variabl
record
admiss
reveal
age
p
fever
p
prematur
birth
p
bpd
p
chd
p
sever
neurolog
impair
p
associ
sever
bc
univari
analys
main
virus
hrsv
hmpv
hbov
hrv
viral
coinfect
hrv
infect
associ
sever
bc
p
dual
infect
hrv
hrsv
viral
coinfect
reach
statist
signific
tabl
show
result
univari
analysi
bacteri
coinfect
introduc
univari
analysi
data
avail
patient
admiss
introduc
signific
variabl
potenti
confound
univari
analysi
adjust
final
model
sever
diseas
accord
bc
includ
bpd
ci
p
hemodynam
signific
chd
ci
p
gestat
age
week
ci
p
temperatur
ci
p
hrv
hrsv
age
p
exclud
final
model
e
tabl
show
result
multivari
logist
regress
model
confid
interv
develop
molecular
techniqu
viru
detect
shown
import
virus
addit
hrsv
pathogenesi
acut
bronchiol
studi
analys
first
time
rel
import
clinic
virolog
data
predict
bronchiol
outcom
result
show
environ
clinic
data
obtain
admiss
relev
specif
infect
viru
determin
risk
sever
diseas
strength
studi
prospect
enrol
hospit
infant
less
month
age
first
acut
episod
bronchiol
exclud
patient
recurr
wheez
wherea
studi
retrospect
investig
result
virolog
examin
patient
differ
age
variou
respiratori
diseas
also
studi
signific
respiratori
virus
current
associ
bronchiol
result
studi
offer
homogen
wellcharacter
cohort
examin
natur
histori
risk
factor
acut
bronchiol
studi
defin
sever
accord
need
picu
admiss
picu
admiss
criteria
differ
center
accord
individu
practic
guidelin
picu
avail
analyz
sever
base
bc
reproduc
clinic
score
allow
classif
patient
accord
respiratori
find
physic
examin
oxygen
satur
reflect
sever
term
respiratori
burden
bc
correl
variabl
involv
sever
length
stay
need
supplementari
oxygen
need
picu
admiss
respiratori
support
univari
logist
regress
analysi
hrv
viru
found
risk
factor
sever
bc
acut
bronchiol
find
accord
report
papadopoulo
et
al
presenc
hrv
infant
bronchiol
found
increas
risk
sever
diseas
defin
clinic
score
admiss
percentil
report
also
describ
hrv
import
pathogen
lower
respiratori
tract
implic
sever
respiratori
distress
children
underli
chronic
condit
significantli
associ
increas
rate
hospit
especi
patient
histori
wheez
asthma
seri
proport
expreterm
infant
underli
chronic
ill
lower
hrsv
bronchiol
bronchiol
caus
virus
accord
previou
studi
describ
major
children
hrsv
infect
develop
countri
underli
medic
condit
high
palivizumab
prophylaxi
rate
environ
could
play
role
lower
hospit
rate
hrsv
bronchiol
highrisk
infant
studi
report
increas
risk
sever
bronchiol
dual
viral
infect
even
specif
viral
infect
hrsvhmpv
coinfect
result
accord
seri
find
increas
sever
patient
viral
coinfect
moreov
high
frequenc
viral
coinfect
studi
also
found
previou
work
indic
infect
multipl
virus
infant
common
situat
chang
clinic
cours
bronchiol
multivari
logist
regress
model
show
bpd
strongest
predictor
sever
score
follow
hemodynam
signific
chd
prematur
wellknown
risk
factor
sever
hrsv
bronchiol
accord
previou
report
last
predictor
analysi
fever
admiss
significantli
associ
xray
infiltr
seri
find
also
describ
previou
work
pulmonari
consolid
chest
xray
associ
sever
diseas
need
respiratori
support
even
previous
healthi
infant
studi
regard
risk
factor
sever
bronchiol
conduct
children
infect
hrsv
knowledg
studi
analyz
risk
factor
patient
bronchiol
rel
import
virus
tradit
risk
factor
result
interest
conclus
drawn
besid
implic
viru
classic
risk
factor
hrsv
bronchiol
extend
includ
bronchiol
caus
virus
observ
import
plan
protocol
bronchiol
manag
although
palivizumab
prophylaxi
administ
highrisk
patient
sever
hrsv
bronchiol
continu
risk
sever
bronchiol
virus
effort
educ
caretak
prevent
viral
infect
highrisk
patient
continu
especi
moder
preterm
infant
bpd
chd
concern
addit
hrv
taken
account
area
univers
hrsv
prophylaxi
highrisk
patient
hrv
associ
sever
case
clinic
factor
consid
routin
screen
hrv
admiss
may
propos
order
identifi
infant
risk
sever
diseas
separ
hospit
patient
cohort
avoid
nosocomi
infect
evalu
find
present
studi
limit
must
highlight
first
studi
conduct
one
season
sever
infect
viru
fluctuat
differ
season
pattern
circul
virus
commun
may
explain
differ
sever
specif
virus
found
report
also
high
palivizumab
prophylaxi
rate
popul
probabl
lead
underestim
role
hrsv
highrisk
infant
anoth
limit
bc
yet
valid
instrument
bronchiol
score
nevertheless
none
avail
score
system
bronchiol
valid
neither
test
characterist
studi
reliabl
respons
reproduc
bc
implement
daili
clinic
practic
institut
year
show
good
correl
outcom
sever
length
hospit
stay
day
oxygen
therapi
nasogastr
feed
tub
fio
greater
picu
admiss
need
respiratori
support
use
differ
bronchiol
score
system
common
limit
articl
field
difficult
compar
studi
final
pathogen
detect
nasopharynx
may
accur
correl
infect
lower
respiratori
tract
addit
detect
virus
might
reflect
late
shed
past
infect
nevertheless
limit
common
similar
report
use
realtim
pcr
viral
load
quantif
may
annul
limit
upcom
project
summari
analyz
rel
import
clinic
factor
specif
virus
predict
sever
bronchiol
data
suggest
although
hrv
seem
relat
increas
risk
sever
diseas
univari
analysi
tradit
clinic
risk
factor
specif
weight
predict
bronchiol
outcom
